These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22655217)

  • 1. Changes of TSH-Stimulation Blocking Antibody (TSBAb) and Thyroid Stimulating Antibody (TSAb) Over 10 Years in 34 TSBAb-Positive Patients with Hypothyroidism and in 98 TSAb-Positive Graves' Patients with Hyperthyroidism: Reevaluation of TSBAb and TSAb in TSH-Receptor-Antibody (TRAb)-Positive Patients.
    Takasu N; Matsushita M
    J Thyroid Res; 2012; 2012():182176. PubMed ID: 22655217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TSBAb (TSH-stimulation blocking antibody) and TSAb (thyroid stimulating antibody) in TSBAb-positive patients with hypothyroidism and Graves' patients with hyperthyroidism.
    Takasu N; Yamashiro K; Ochi Y; Sato Y; Nagata A; Komiya I; Yoshimura H
    Horm Metab Res; 2001 Apr; 33(4):232-7. PubMed ID: 11383928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects.
    Takasu N; Oshiro C; Akamine H; Komiya I; Nagata A; Sato Y; Yoshimura H; Ito K
    J Endocrinol Invest; 1997 Sep; 20(8):452-61. PubMed ID: 9364248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenetic role of thyrotropin receptor antibody in the development of hyperthyroidism following primary hypothyroidism.
    Shong YK; Cho BY; Hong SK; Lee HK; Koh CS; Min HK
    Korean J Intern Med; 1989 Jul; 4(2):118-24. PubMed ID: 2577256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of thyroid stimulating antibody (TSAb) in the thyroid function of patients with post-partum hypothyroidism.
    Hara T; Tamai H; Mukuta T; Fukata S; Kuma K
    Clin Endocrinol (Oxf); 1992 Jan; 36(1):69-74. PubMed ID: 1348451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Goitrous hypothyroidism with blocking or stimulating thyrotropin binding inhibitor immunoglobulins.
    Sato K; Okamura K; Yoshinari M; Ikenoue H; Kuroda T; Torisu M; Fujishima M
    J Clin Endocrinol Metab; 1990 Oct; 71(4):855-60. PubMed ID: 1976127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease].
    Chen W; Man N; Li YS; Shan ZY; Teng WP
    Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):95-9. PubMed ID: 16624113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment.
    Takasu N; Yamashiro K; Komiya I; Ochi Y; Sato Y; Nagata A
    Thyroid; 2000 Oct; 10(10):891-6. PubMed ID: 11081255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Graves' disease following hypothyroidism due to Hashimoto's disease: studies of eight cases.
    Takasu N; Yamada T; Sato A; Nakagawa M; Komiya I; Nagasawa Y; Asawa T
    Clin Endocrinol (Oxf); 1990 Dec; 33(6):687-98. PubMed ID: 1982861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves' disease.
    Takasu N; Kamijo K; Sato Y; Yoshimura H; Nagata A; Ochi Y
    Clin Exp Pharmacol Physiol; 2004; 31(5-6):314-9. PubMed ID: 15191404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulating and blocking thyroid-stimulating hormone (TSH) receptor autoantibodies from patients with Graves' disease and autoimmune hypothyroidism have very similar concentration, TSH receptor affinity, and binding sites.
    Morgenthaler NG; Ho SC; Minich WB
    J Clin Endocrinol Metab; 2007 Mar; 92(3):1058-65. PubMed ID: 17179194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hashimoto's thyroiditis: TGAb, TPOAb, TRAb and recovery from hypothyroidism.
    Takasu N; Yoshimura Noh J
    Expert Rev Clin Immunol; 2008 Mar; 4(2):221-37. PubMed ID: 20477052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graves' hyperthyroidism showing transient hypothyroidism during interferon therapy for chronic hepatitis type C.
    Inoue A; Koizumi S; Matsuda A; Mizuo H; Iriuda Y; Ikota A; Beniko M; Kosugi T; Matsuya K; Kunita H; Mashio Y
    Endocr J; 2005 Jun; 52(3):293-8. PubMed ID: 16006723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
    Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of infiltrative ophthalmopathy in parallel with decrease of thyroid-stimulating antibody (TSAb) activity in two patients with hypothyroid Graves' disease.
    Tamaki H; Amino N; Iwatani Y; Miyai K
    J Endocrinol Invest; 1989 Jan; 12(1):47-53. PubMed ID: 2568374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmunity and hypothyroidism.
    Amino N
    Baillieres Clin Endocrinol Metab; 1988 Aug; 2(3):591-617. PubMed ID: 3066320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of circulating anti-thyroid stimulating hormone (TSH) receptor antibodies in patients with autoimmune thyroid diseases--thyroid stimulation blocking antibody in patients with Graves' disease].
    Fujihira T
    J UOEH; 1989 Dec; 11(4):393-401. PubMed ID: 2575267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism of spontaneous hypothyroidism in patients with Graves' disease after antithyroid drug treatment.
    Tamai H; Hirota Y; Kasagi K; Matsubayashi S; Kuma K; Iida Y; Konishi J; Okimura MC; Walter RM; Kumagai LF
    J Clin Endocrinol Metab; 1987 Apr; 64(4):718-22. PubMed ID: 2434520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the properties of the thyrotropin receptor antibody in patients with Graves' disease after radioiodine treatment.
    Cho BY; Shong YK; Chung JK; Lee MC; Lee HK; Koh CS; Min HK
    Thyroidology; 1989 Dec; 1(3):109-14. PubMed ID: 2484872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the properties of the thyrotropin receptor antibody in patients with Graves' disease after radioiodine treatment.
    Cho BY; Shong YK; Chung JK; Lee MC; Lee HK; Koh CS; Min HK
    Korean J Intern Med; 1990 Jan; 5(1):51-7. PubMed ID: 1980206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.